Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.
Also called NCT04850417
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 600 participants
- Registry
-
NCT04850417
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT04850417. Randomized; single masking; primary purpose treatment. Start 2021-04-30 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection
- Acronym
- BA-SCAD
- Condition
- Spontaneous Coronary Artery Dissection
- Intervention (Drug)
- Beta blocker, aspirin, clopidogrel
- Lead sponsor
- Spanish Society of Cardiology
- Collaborator
- Instituto de Investigación Sanitaria Hospital Universitario de la Princesa
- Collaborator
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Record details
- Record id
cardio:ct-nct04850417- Content hash
800ea911b42da6baefd3443382ce527c826b780def18b99a7e09b1735519d9ab